Literature DB >> 7219635

Tissue and blood cell concentration of methylguanidine in rats and patients with chronic renal failure.

Y Orita, A Ando, Y Tsubakihara, H Mikami, T Kikuchi, K Nakata, H Abe.   

Abstract

Methylguanidine concentration in blood cell of nondialysed patients with chronic renal failure was quantitatively determined by the method of the present authors. We also determined tissue methylguanidine concentrations in the liver, blood cell, kidney, colon, muscle and brain of uremic rat experimentally produced by Platt's method. Methylguanidine concentrations in blood cell and tissues except the brain of the uremic rats and in blood cell of the uremic patients were 5--7 times higher than those in their serums. An increased methylguanidine concentration in the liver of the uremic rat receiving 40% protein diet was observed. These results imply that methylguanidine acts as one of the important uremic toxins in the intracellular space except for the brain, and suggest that the liver specifically affects the formation of methylguanidine.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7219635     DOI: 10.1159/000182017

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  2 in total

1.  Effect of recombinant human erythropoietin on synthesis of methylguanidine in uraemic patients on haemodialysis or continuous ambulatory peritoneal dialysis.

Authors:  I Sasagawa; T Nakada; Y Kubota; T Sawamura; H Suzuki; T Hashimoto
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

2.  Effect of methylguanidine on rat blood pressure: role of endothelial nitric oxide synthase.

Authors:  R Sorrentino; A Pinto
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.